A First-in-human Study to Evaluate the Safety and Tolerability of AZD8853 in Participants With Selected Advanced/Metastatic Solid Tumours

Clinical trial NCT05397171 · TERMINATED

Trial details

NCT number: NCT05397171
Sponsor: AstraZeneca
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Urinary Bladder Neoplasms Colorectal Cancer Carcinoma, Non-Small-Cell Lung

Start date: 2022-06-07
Primary completion: 2023-06-06
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.